Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648632 | 0.94 | DYRK1A (0.33) | DYRK1A | |
| SCHEMBL650203 | 0.94 | DYRK1A (0.33) | DYRK1A | |
| SCHEMBL12591168 | 0.89 | DYRK1A (0.31) | DYRK1A | |
| SCHEMBL12591167 | 0.86 | — | — | |
| SCHEMBL336442 | 0.85 | CACNA2D1 (0.37) | — | |
| SCHEMBL29360481 | 0.85 | CACNA2D1 (0.37) | — | |
| SCHEMBL12590007 | 0.85 | ELANE (0.32) | — | |
| SCHEMBL18267813 | 0.84 | CACNA2D1 (0.36) | — | |
| SCHEMBL1270205 | 0.82 | CACNA2D1 (0.35) | — | |
| SCHEMBL14514097 | 0.82 | CACNA2D1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101776-B2 | Organic semiconductors and their manufacture | BASF SE (DE) | 2012-01-24 | — | — | US | disclosed |
| US-8101776-B2 | Organic semiconductors and their manufacture | BASF SE (DE) | 2012-01-24 | — | — | US | disclosed |
| US-7935960-B2 | organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances | MERCK PATENT GMBH (DE) | 2011-05-03 | — | — | US | disclosed |
| US-7935960-B2 | organic field effect transistors; introducing asymmetry into the polyacene derivative affects its solid-state order; combining with organic binder resin results in little or no reduction in charge mobility of the polyacene, even an increase in some instances | MERCK PATENT GMBH (DE) | 2011-05-03 | — | — | US | disclosed |
| US-20100308304-A1 | ELECTRONIC SHORT CHANNEL DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR FORMULATION | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | CLAP CO., LTD. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | CLAP CO., LTD. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | FLEXENABLE TECHNOLOGY LIMITED (GB) | 2008-08-14 | — | — | US | disclosed |
| US-20080142793-A1 | Organic Semiconductors | UNITED STATES AIR FORCE | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080191199-A1 | Polyacene and Semiconductor Formulation | OR51E2, PIEZO1, FDFT1 | DYRK1A 2867/4885 |
| US-20080142793-A1 | Organic Semiconductors | ACE, ACE2, TTN | DYRK1A 1462/4885 |
| US-20090299070-A1 | Organic Semiconductors and Their Manufacture | YBX1, CDYL, PROX1 | DYRK1A 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.